Deerfield strikes up new deal with Columbia University; Ovid CEO Jeremy Levin joins BIO as new board chair
→ In its latest deal, healthcare investment firm Deerfield Management and Columbia University have collaborated to launch Hudson Heights Innovations “to catalyze the development of novel therapeutics out of the research labs of Columbia University”. Deerfield and its partners will provide up to $130 million in initial funding to back the initiative for over 10 years.
“Much of our research is aimed at understanding at the molecular level how diseases develop and how we can intervene with drugs or other therapeutics,” said Lee Goldman, dean of the faculties of health sciences and medicine and chief executive of Columbia University Irving Medical Center.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.